By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Janssen Pharmaceutical Inc.  

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: 609-730-2000 Fax: n/a



Company News
Janssen Pharmaceutical Completes Divestiture Of U.S. License Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended-Release Tablets And NUCYNTA (tapentadol) Oral Solution To Depomed, Inc. (DEPO) 4/3/2015 6:34:27 AM
Depomed, Inc. (DEPO) Announces Closing Of Acquisition Of U.S. Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended Release Tablets And NUCYNTA (tapentadol) Oral Solution From Janssen Pharmaceutical For $1.05 Billion 4/2/2015 3:11:25 PM
Johnson & Johnson (JNJ)'s Janssen Pharmaceutical Snaps Up Virtual Biopharma XO1 Limited for Hush Hush Price 3/19/2015 6:07:46 AM
Depomed, Inc. (DEPO) Announces Termination Of Hart-Scott-Rodino Waiting Period For Pending Acquisition Of NUCYNTA Franchise From Janssen Pharmaceutical Inc. 3/17/2015 7:43:02 AM
Webinar Showcasing How Janssen Pharmaceutical Inc. Addressed Barcode Labeling Challenges In An SAP Environment 2/17/2015 10:55:11 AM
Evotec AG (EVTG.F) Achieves Further Milestones In TargetAD Collaboration With Janssen Pharmaceutical Inc. 1/15/2015 7:08:47 AM
Janssen Pharmaceutical Inc. Release: Real-World Data Published In Clinical Cardiology Show Consistent Safety Performance Of Once-Daily XARELTO® 1/14/2015 8:04:00 AM
X-Chem Announces Collaboration With Janssen Pharmaceutical Inc. And Johnson & Johnson Innovation (JNJ) Innovation To Advance Novel Candidates To Treat Inflammatory Diseases 1/9/2015 10:28:49 AM
Sevion Announces Antibody Discovery Collaboration With Johnson & Johnson Innovation (JNJ) And Janssen Pharmaceutical Inc. 12/22/2014 8:51:44 AM
Janssen Pharmaceutical Inc. Teams Up With The American Diabetes Association To Take On Type 2 Diabetes 12/8/2014 9:24:04 AM